Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Omeprazole on Fluzoparib PK in Healthy Males
NCT04108676Phase 1Completed
- Sponsor
- Hengrui
- Start
- Sep 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fluzoparib in solid tumor (advanced stage) and ovarian cancer, sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration at Day 9, Area Under the Plasma Concentration-Time Curve From 0 to t at Day 9 and 1 more. Started Sep 2019; status: completed.
02
Drugs
fluzoparib
03
Conditions
solid tumor (advanced stage)ovarian cancer
Beyond the preview
Go deeper on NCT04108676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04108676.